ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Chemotherapy After Surgery Extends Survival By 32%

January 27, 2006

Construction, Pay Raise, Foundation Bills Clear Senate Committee

December 1, 1989

Low-Dose Aspirin Cuts Risk Of Colorectal Growths

April 26, 2002

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

HHS Approves Six State Plans To Insure Women With Cancer

June 8, 2001

NCAB Asks Speedup Of OSP Coordinating Center Review

October 14, 1983